Entries by Sydney Stressman

Penn gene therapy spinout exceeds projections with $216M IPO

Penn Medicine spinout Passage Bio raised $216 million through an initial public offering to support the continued development of clinical trials for gene therapies to treat rare central nervous system disorders – exceeding expectations and proving that cell and gene therapies can thrive in the Greater Philadelphia region. Article from the Philadelphia Business Journal

New Development Coming to uCity Square

Development for One uCity Square officially broke ground in late January and is expected to finish by the end of 2021. The University City Science Center, Ventas Inc., and Wexford Science and Technology have partnered to create the $280 million, 400,000-square-foot building. Developers fully expect that the new building will be in high demand once […]

A cell and gene therapy development center is taking 680K square feet at KOP’s Discovery Labs

New York-based Deerfield Management and King of Prussia’s The Discovery Labs will open the Center for Breakthrough Medicines, occupying 680,000 square feet of The Discovery Labs space to provide pre-clinical through commercial manufacturing of cell and gene therapies, adding to our rich ecosystem as a cell and gene therapy hub. Article from Technical.ly